Cite

HARVARD Citation

    Caudle, K. et al. (2014). Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing. Clinical pharmacology & therapeutics. 96 (5), pp. 542-548. [Online]. 
  
Back to record